MedPath

远大医药黄石飞云制药有限公司

Ownership
-
Established
2013-02-22
Employees
-
Market Cap
-
Website
http://www.hs-fy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

95

NMPA:95

Drug Approvals

Oxaliplatin

Product Name
奥沙利铂
Approval Number
国药准字H20093751
Approval Date
Aug 15, 2024
NMPA

麝香祛痛搽剂

Approval Number
国药准字Z20093164
Approval Date
Nov 3, 2023
NMPA

Gemcitabine Hydrochloride for Injection

Product Name
注射用盐酸吉西他滨
Approval Number
国药准字H20133194
Approval Date
Jun 16, 2023
NMPA

Glipizide Capsules

Product Name
格列吡嗪胶囊
Approval Number
国药准字H20083314
Approval Date
Apr 11, 2023
NMPA

Fluorouracil for Injection

Product Name
注射用氟尿嘧啶
Approval Number
国药准字H20051137
Approval Date
Dec 2, 2021
NMPA

Fluorouracil for Injection

Product Name
注射用氟尿嘧啶
Approval Number
国药准字H20051138
Approval Date
Dec 2, 2021
NMPA

新生化颗粒

Approval Number
国药准字Z20064258
Approval Date
Jul 14, 2021
NMPA

新生化颗粒

Approval Number
国药准字Z20064259
Approval Date
Jul 14, 2021
NMPA

阿归养血糖浆

Approval Number
国药准字Z42021553
Approval Date
Sep 8, 2020
NMPA

清热解毒口服液

Approval Number
国药准字Z42021603
Approval Date
Sep 8, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.